Fri 25'th May 2018
Eleven Biotherapeutics Stock Analysis
Technical stock analysis for Fri 25'th May 2018
No changes to the price of Eleven Biotherapeutics in the last trading day. The price has been going up and down for this period, and there has been a 17.08% gain for the last 2 weeks.
|Shorts||0.78% ( 2018-04-30 )|
Eleven Biotherapeutics lies in the middle of a very wide and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 227.91% during the next 3 months and, with 90% probability hold a price between $8.79 and $13.10 at the end of this period.
Eleven Biotherapeutics holds buy signals from both short- and long-term moving averages. In addition, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down there will be some support from the lines at $3.29 and $2.52. A break down below any of these levels will issue sell signals. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sales signal was issued from a pivot top point on Thursday May 24, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell on the last day without any changes to the price. This does not cause any direct divergence but may be an early warning and a possible "turning point". The very low volume increases the risk and reduces the other technical signals issued.
Relative Strength Index (RSI)
RSI14 is 60 and the stock is currently not being overbought or oversold
Support & Resistance
Eleven Biotherapeutics finds support from accumulated volume at $3.22.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.00 between high and low, or 0.00%. For the last week the stock has had a daily average volatility of 0.00%.
Our recommended stoploss: $3.16 (-3.80%) (This stock has very high daily movements and this gives very high risk. There is a sell signal from pivot top found 1 days ago.)
Very Low Low Medium High Very High
Trade EBIO CFDs with Plus500
Your capital is at risk.
Important: Plus500 doesn't offer signals and it is a CFD service.
Plus500UK Ltd is authorised and regulated by the Financial Conduct Authority (FRN 509909).
Access these features
Auto portfolios gaining up to 30%
Top 5 Candidates in all Lists
Ultimate List Builder